范跃祖 - 同济大学

个人简介

同济大学外科学教授、主任医师、博士生导师；同济大学附属同济医院大外科、外科教研室主任；国际胃肠外科俱乐部、欧洲消化外科学会会员，中国医师协会外科医师分会、上海市医学会外科学会、普外科专业分会、普外科胆道外科和胰腺外科专业组委员，上海市中西医结合外科学会常委，国家自然科学基金委员会（生命科学部-肿瘤/普外）、国家及上海市继续医学教育项目评审专家，上海市医疗事故技术鉴定专家，《World Journal Gastrointestinal Surgery》、《Molecular and Clinical Oncology》杂志编委，《中国医学文摘外科学(英文版)》、《外科研究与新技术（中英文杂志）》副主编。

研究领域

胆胰外科疾病和消化系肿瘤的外科综合治疗及其相关基础研究

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Fan YZ, Zhao ZM, Fu JY, Chen CQ, Sun W. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo. Hepatobiliary Pancreat Dis Int 2010; 9(4): 414-422 Ge BJ, Huang Q, Liu LM, Bian HP, Fan YZ. Risk factors for bowel resection and outcome in patients with incarcerated groin hernias. Hernia 2010; 14(3): 259–264. Fan YZ, Sun W. Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.World J Gastrointestinal Surgery 2010; 2(4):117-127 Li XP, Liu WF, Ji SR, Wu SH, Sun JJ, Fan YZ. Isolated pancreatic granulocytic sarcoma: A case report and review of the literature. World J Gastroenterol 2011; 17(4): 540-542 Sun W, Fan YZ, Zhang WZ, Ge CY. A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro. J Exp Clin Cancer Res 2011, 30:46-58 Sun W, Fan YZ, Xi H. Astrocyte elevated gene-1 (AEG-1) overexpression in human primary gallbladder carcinomas: an unfavorable and independent prognostic factor. Oncol Rep 2011; 26(5):1133-1142 Zhang JT, Fan YZ, Chen CQ, Zhao ZM, Sun W. Norcantharidin: A potential antiangiogenic agent for gallbladder cancers in vitro and in vivo. Int J Oncol 2012, 40(5):1501-1514 Zhang JT, Fan YZ, Chen CQ, Zhao ZM, Sun W. Norcantharidin: A potential antiangiogenic agent for gallbladder cancers in vitro and in vivo. Int J Oncol 2012, 40(5):1501-1514 Sun W, Shen ZY, Zhang H, Fan YZ, Zhang WZ, Zhang JT, Lu XS, Ye C. Overexpression of HIF-1α in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavorable prognosis. Oncol Reports 2012, 27(6):1990-2002 Sun JJ, Jing W, Ni YY, Yuan XJ, Zhou HH, Fan YZ. New model of in-situ xenograft lymphangiogenesis by a human colonic adenocarcinoma cell line in nude mice. Asian Pacific J Cancer Prev 2012, 13(6):2823-2828 Liu ZY, Qiu HO, Yuan XJ, Ni YY, Sun JJ, Jing W, Fan YZ. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and -D/VEGFR-3 with norcantharidin. Int J Oncol2012, 41(5):1762-1772 Zhang JT, Fan YZ, Chen CQ, Zhao ZM, Sun W. Norcantharidin: A potential antiangiogenic agent for gallbladder cancers in vitro and in vivo. Int J Mol Med 2012, 30(Suppl 1):S39 Liu ZY, Qiu HO, Yuan XJ, Ni YY, Sun JJ, Jing W, Fan YZ. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and -D/VEGFR-3 with norcantharidin. Int J Mol Med 2012, 30(Suppl 1):S40 Lu XS, Sun W, Ge CY, Zhang WZ, Fan YZ. Contribution of the PI3-K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas. Int J Oncol 2013, 42(6):2103-2115 Zhang JT, Sun W, Zhang WZ, Ge CY, Liu ZY, Zhao ZM, Lu XS, Fan YZ. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway. BMC Cancer 2014, 14:193. Wang H, Sun W, Zhang WZ, Ge CY, Zhang JT, Liu ZY, Fan YZ. Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/Paxillin signaling pathway. PLoS One 2014, 9(5): e96882. Zhu W, Sun W, Zhang JT, Liu ZY, Li XP, Fan YZ. Norcantharidin enhances TIMP-2 anti-vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP-2 and MT1-MMP. Int J Oncol 2015, 46:627-640 Yuan XJ, Chen Y, Li XM, Zhang GN, Jin DH, Zhao HF, Su ZW, Fan YZ. Norcantharidin inhibits lymphangiogenesis by downregulating the expression of VEGF-C and VEGF-D in human dermal lymphatic endothelial cells in vitro. Pharmacology 2015(1-), 95:1-9 Li XP, Jin W, Sun JJ, Liu ZY, Zhang JT, Sun W, Zhu W, Fan YZ. Norcantharidin, a potential small-molecule synthetic antilymphangiogenic agent, inhibits colonic adenocarcinoma lymphangiogenesis through arresting S-phasecell cycle and VEGF-A, -C, -D/VEGFR-2, -3 signaling pathways in vitro and in vivo. Eur Surg 2015, 47(Suppl 1): S75-S76 Li XP, Jin W, Sun JJ, Liu ZY, Zhang JT, Sun W, Zhu W, Fan YZ. A potential small-molecule syntheticantilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A, -C, -D/VEGFR-2,-3 “multi-points priming” mechanisms in vitro andin vivo. BMC Cancer 2015, 15:527